Andreas Buser

12.4k total citations · 2 hit papers
151 papers, 6.2k citations indexed

About

Andreas Buser is a scholar working on Hematology, Genetics and Biochemistry. According to data from OpenAlex, Andreas Buser has authored 151 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 39 papers in Genetics and 23 papers in Biochemistry. Recurrent topics in Andreas Buser's work include Hematopoietic Stem Cell Transplantation (33 papers), Blood transfusion and management (23 papers) and Hemoglobinopathies and Related Disorders (22 papers). Andreas Buser is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Blood transfusion and management (23 papers) and Hemoglobinopathies and Related Disorders (22 papers). Andreas Buser collaborates with scholars based in Switzerland, United States and Netherlands. Andreas Buser's co-authors include André Tichelli, Radek C. Skoda, Róbert Královics, Jakob Passweg, Ralph Tiedt, Mario Cazzola, Francesco Passamonti, Laura Infanti, Hans H. Hirsch and Adrian Egli and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Andreas Buser

136 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

2005 2.6k citations Róbert Královics, Andreas Buser et al. profile →
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors

2009 603 citations Adrian Egli, Laura Infanti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Buser Switzerland	30	3.2k	2.9k	2.0k	1.4k	1.3k	151	6.2k
Alberto Bosi Italy	57	3.6k 1.1×	6.1k 2.1×	2.3k 1.2×	2.3k 1.7×	1.0k 0.8×	321	10.5k
Andrew Grigg Australia	48	3.8k 1.2×	5.0k 1.7×	1.3k 0.6×	2.2k 1.6×	1.8k 1.4×	274	8.8k
Peter Dreger Germany	58	3.6k 1.1×	5.4k 1.8×	1.4k 0.7×	4.6k 3.4×	211 0.2×	408	11.6k
Mauricette Michallet France	50	2.2k 0.7×	6.9k 2.4×	2.0k 1.0×	2.6k 1.9×	529 0.4×	311	10.0k
Naval Daver United States	58	3.4k 1.1×	9.2k 3.1×	5.9k 3.0×	4.5k 3.3×	670 0.5×	622	14.5k
Marcos de Lima United States	62	2.3k 0.7×	9.2k 3.1×	2.0k 1.0×	3.5k 2.6×	279 0.2×	421	12.7k
Chitra Hosing United States	51	1.5k 0.5×	5.1k 1.7×	1.3k 0.7×	3.2k 2.4×	215 0.2×	372	8.9k
Koen van Besien United States	57	2.6k 0.8×	6.9k 2.4×	1.2k 0.6×	4.4k 3.2×	309 0.2×	354	12.0k
Ibrahim Yakoub‐Agha France	47	1.1k 0.4×	4.7k 1.6×	1.4k 0.7×	2.8k 2.1×	274 0.2×	407	7.6k
Patrizia Chiusolo Italy	33	1.0k 0.3×	2.0k 0.7×	800 0.4×	664 0.5×	536 0.4×	212	4.3k

Countries citing papers authored by Andreas Buser

Since Specialization

Citations

This map shows the geographic impact of Andreas Buser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Buser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Buser more than expected).

Fields of papers citing papers by Andreas Buser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Buser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Buser. The network helps show where Andreas Buser may publish in the future.

Co-authorship network of co-authors of Andreas Buser

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Buser. A scholar is included among the top collaborators of Andreas Buser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Buser. Andreas Buser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bolliger, Daniel, Andreas Buser, & Kenichi A. Tanaka. (2025). Outcomes, cost-effectiveness, and ethics in patient blood management. Current Opinion in Anaesthesiology. 38(2). 151–156. 1 indexed citations

Serricchio, Mauro, Peter Gowland, Sophie Waldvogel, et al.. (2025). Surveillance of blood donors detects an exceptional Parvovirus B19 outbreak in Switzerland in 2023/2024.. PubMed. 23(6). 515–522. 1 indexed citations

Zingg, Andreas, Reto Ritschard, Helen Thut, et al.. (2025). Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. Cancer Immunology Research. 13(7). 990–1003.

Niederhauser, Christoph, Caroline Tinguely, Stefano Fontana, et al.. (2025). Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. Viruses. 17(10). 1292–1292.

Volken, Thomas, Beatrice Drexler, Laura Infanti, et al.. (2023). Safety and Feasibility of Immunoadsorption with Heparin Anticoagulation in Preparation of ABO-Incompatible Kidney Transplantation: A Retrospective Single-Center Study. Transfusion Medicine and Hemotherapy. 50(2). 76–87. 2 indexed citations

Berg, J., Jasmin D. Haslbauer, Anna K. Stalder, et al.. (2023). Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies. Research and Practice in Thrombosis and Haemostasis. 7(4). 100182–100182. 9 indexed citations

Hollinger, Alexa, Atanas Todorov, Caroline E. Gebhard, et al.. (2023). Impact of Additional Administration of von Willebrand Factor Concentrates to Thrombocyte Transfusion in Perioperative Bleeding in Cardiac Surgery. Transfusion Medicine and Hemotherapy. 51(1). 22–31.

Infanti, Laura, Sandra Mitrović, Andreas Holbro, et al.. (2022). Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light. Transfusion Medicine. 32(6). 505–511. 2 indexed citations

Buser, Andreas, et al.. (2022). Treatment Strategies in Anemic Patients Before Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 37(2). 266–275. 13 indexed citations

10.

Battegay, R, Andreas Holbro, Andreas Buser, et al.. (2021). Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data. Swiss Medical Weekly. 151(4950). w30084–w30084. 8 indexed citations

11.

Volken, Thomas, Jakob Passweg, Jörg Halter, et al.. (2021). Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation. Transfusion and Apheresis Science. 61(2). 103301–103301. 1 indexed citations

12.

Holbro, Andreas, et al.. (2019). The Remarkable Journey of a Low-Frequency Alloantibody. Transfusion Medicine and Hemotherapy. 46(5). 384–385. 1 indexed citations

13.

Tichelli, André, Sabine Gerull, Andreas Holbro, et al.. (2017). Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplantation. 52(10). 1436–1442. 17 indexed citations

14.

Meyer, Sara C., Simona Stivala, Anne Baerenwaldt, et al.. (2017). Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms. Bern Open Repository and Information System (University of Bern). 4 indexed citations

15.

Egli, Adrian, Christoph Bucher, Alexis Dumoulin, et al.. (2012). Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection. 40(6). 677–684. 33 indexed citations

16.

Meyer, Sara C., Alix O’Meara, Andreas Buser, et al.. (2012). Prognostic Impact of Posttransplantation Iron Overload after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(3). 440–444. 45 indexed citations

17.

O’Meara, Alix, Jörg Halter, Dominik Heim, et al.. (2012). Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI. Biology of Blood and Marrow Transplantation. 19(1). 82–86. 4 indexed citations

18.

Medinger, Michael, Elisabeth Saller, Cornelis L. Harteveld, et al.. (2011). A Rare Case of Coinheritance of Hemoglobin H Disease and Sickle Cell Trait Combined with Severe Iron Deficiency. SHILAP Revista de lepidopterología. 3(3). e30–e30. 2 indexed citations

19.

Liu, Kai, Róbert Královics, Zbigniew Rudzki, et al.. (2008). A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica. 93(5). 706–714. 32 indexed citations

20.

Martínez, María Teresa, Georg Stüssi, Dominik Heim, et al.. (2005). Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplantation. 36(11). 993–1000. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact